Modulation of immunologic responses to HIV-1 MN recombinant gp160 vaccine by dose and schedule of administration

By National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group   Gorse G.J.   McElrath M.J.   Matthews T.J.   Hsieh R.-H.   Belshe R.B.   Corey L.   Frey S.E.   Kennedy D.J.   Walker M.C.   Eibl M.M.  

Vaccine, Vol. 16, Iss. 5, 1998-03 ,pp. : 493-506

Elsevier

Access to resources Recommend Favorite

Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons

By Vinner L.   Nielsen H.V.   Bryder K.   Corbet S.   Claus Nielsen   Fomsgaard A.  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2166-2175

Elsevier

Access to resources Recommend Favorite

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

By Barnett S.W.   Rajasekar S.   Legg H.   Doe B.   Fuller D.H.   Haynes J.R.   Walker C.M.   Steimer K.S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 869-873

Elsevier

Access to resources Recommend Favorite

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva

By NIAID AIDS   Gorse G.J.   Rogers J.H.   Perry J.E.   Newman F.K.   Frey S.E.   Patel G.B.   Belshe R.B.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 209-214

Elsevier

Access to resources Recommend Favorite

Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): Effects of administration of Zidovudine in vivo and interleukin-2 in vitro

By Pierdominici M.   Mollicone B.   Ricci G.   Oliva A.   D'Offizi G.   Giovannetti A.   Aiuti F.   Pandolfi F.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 715-721

Elsevier

Access to resources Recommend Favorite